NEPTUNUS(SZ:000078)2022-12-07 08:34Group 1: Product Advantages - The company's Tegio tablets are the first to be marketed in tablet form, providing a competitive edge over existing capsule forms [1][2] - Clinical trials demonstrate the Tegio tablets' efficacy, tolerability, and convenience, ensuring safety and effectiveness [2] - The tablet formulation minimizes unnecessary excipients, reducing quality and safety risks associated with non-essential ingredients [2] Group 2: Market Position and Strategy - The company has a strong competitive position in tenders, with a high success rate in winning bids due to the unique tablet formulation [2] - The market potential for Tegio tablets is optimistic, with numerous niche markets and relatively few competitors [2] - The company plans to enhance sales through academic promotion and the establishment of a specialized sales team [2] Group 3: Future Expansion Plans - The company is exploring opportunities for private capital investment in healthcare, following successful participation in a hospital project [3] - Future collaborations may include various forms such as equity participation or partnerships, depending on regulatory conditions [3] - The company aims to replicate successful distribution models from its Nanyang subsidiary across other subsidiaries to improve overall profit margins [3]